The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Open accessAbstract
Loss of Treg function appears to be a critical factor in the pathogenesis of human autoimmune diseases. Attention has focused on defects of CD4(+)CD25(high) Tregs, and techniques have been developed to determine their function. In contrast, the role of Tr1 regulatory T cells, which secrete the antiinflammatory cytokine IL-10, in autoimmune disease has not been well assessed. CD46 is a newly defined costimulatory molecule for T cell activation, and CD46-costimulated human T cells induce a Tr1 Treg phenotype with considerable amounts of IL-10 secretion. Here, we examined the role of Tr1 cells in patients with multiple sclerosis (MS) by stimulating CD4(+) T cells with anti-CD3 and -CD46 mAbs and measuring IL-10 secretion. There were striking defects in the induction of Tr1 cells with CD46 costimulation as measured by IL-10 but not IFN-gamma secretion in patients with MS compared with healthy subjects. This loss of Tr1 cell-associated IL-10 secretion was specific to CD46 and not CD28 costimulation and was associated with an altered regulation of the CD46-Cy2 isoform that differentially regulates T cell function in a CD46-transgenic murine model. These data demonstrate a second major Treg defect in human autoimmune disease associated with the CD46 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Self-citationFaria, A. M. C., & Weiner, H. L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00280.x · Cited by 601
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
Kemper, C., Chan, A. C., Green, J. M., Brett, K. A., Murphy, K. M., & Atkinson, J. P. (2003) · Nature · doi:10.1038/nature01315 · Cited by 587
Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3299 · Cited by 556
Grossman, W. J., Verbsky, J. W., Tollefsen, B. L., Kemper, C., Atkinson, J. P., & Ley, T. J. (2004) · Blood · doi:10.1182/blood-2004-03-0859 · Cited by 536
Weiner, H. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10762 · Cited by 450
Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Decreased FOXP3 levels in multiple sclerosis patients
Huan, J., Culbertson, N., Spencer, L., Bartholomew, R., Burrows, G. G., Chou, Y. K., Bourdette, D., Ziegler, S. F., Offner, H., & Vandenbark, A. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20522 · Cited by 369
Kohm, A. P., McMahon, J. S., Podojil, J. R., Begolka, W. S., DeGutes, M., Kasprowicz, D. J., Ziegler, S. F., & Miller, S. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3301 · Cited by 332
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320
Self-citationTr1 cells: From discovery to their clinical application
Battaglia, M., Gregori, S., Bacchetta, R., & Roncarolo, M.-G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.007 · Cited by 279
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Van Boxel-Dezaire, A. H. H., Hoff, S. C. J., Van Oosten, B. W., Verweij, C. L., Dräger, A. M., Adèr, H. J., Van Houwelingen, J. C., Barkhof, F., Polman, C. H., & Nagelkerken, L. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<695::aid-ana3>3.0.co;2-r · Cited by 265
Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., & Baecher‐Allan, C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00240.x · Cited by 260
Self-citationHow do CD4+CD25+ regulatory T cells control autoimmunity?
Bluestone, J. A., & Tang, Q. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.09.002 · Cited by 245
Hohlfeld, R., & Wekerle, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404874101 · Cited by 239
Regulatory T cells: Development, function and role in autoimmunity
LAN, R., ANSARI, A., LIAN, Z., & GERSHWIN, M. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.01.007 · Cited by 224
Four Viruses, Two Bacteria, and One Receptor: Membrane Cofactor Protein (CD46) as Pathogens' Magnet
Cattaneo, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4385-4388.2004 · Cited by 222
CD4+ regulatory T cells: Mechanisms of induction and effector function
Bacchetta, R., Gregori, S., & Roncarolo, M.-G. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.005 · Cited by 215
Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis
Cua, D. J., Groux, H., Hinton, D. R., Stohlman, S. A., & Coffman, R. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.1005 · Cited by 201
Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4CD25 T cells
BAECHERALLAN, C., WOLF, E., & HAFLER, D. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.02.018 · Cited by 180
Self-citationMarie, J. C., Astier, A. L., Rivailler, P., Rabourdin-Combe, C., Wild, T. F., & Horvat, B. (2002) · Nature Immunology · doi:10.1038/ni810 · Cited by 178
Self-citationCorreale, J., Gilmore, W., McMillan, M., Li, S., McCarthy, K., Le, T., & Weiner, L. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2959 · Cited by 165
Astier, A., Trescol-Biémont, M.-C., Azocar, O., Lamouille, B., & Rabourdin-Combe, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6091 · Cited by 161
Self-citationZaffran, Y., Destaing, O., Roux, A., Ory, S., Nheu, T. V., Jurdic, P., Rabourdin‐Combe, C., & Astier, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6780 · Cited by 123
Self-citationInterferon beta induces T-helper 2 immune deviation in MS
Kozovska, M., Hong, J., Zang, Y. C. Q., Li, S., Rivera, V. M., Killian, J. M., & Zhang, J. Z. (1999) · Neurology · doi:10.1212/wnl.53.8.1692 · Cited by 111
Christen, U., & von Herrath, M. G. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.002 · Cited by 80
CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae
Lee, S. W., Bonnah, R. A., Higashi, D. L., Atkinson, J. P., Milgram, S. L., & So, M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109005 · Cited by 78
Özenci, V., Kouwenhoven, M. C. M., Huang, Xiao, X., Kivisäkk, Fredrikson, S., & Link (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00546.x · Cited by 73
A Functional Interaction between CD46 and DLG4
Ludford‐Menting, M., Thomas, S. J., Crimeen, B., Harris, L. J., Loveland, B. E., Bills, M. M., Ellis, S. L., & Russell, S. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108479200 · Cited by 65
T-Cell Stimulation and Regulation: With Complements from CD46
Kemper, C., Verbsky, J. W., Price, J. D., & Atkinson, J. P. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:031 · Cited by 63
Clerici, M., Saresella, M., Trabattoni, D., Speciale, L., Fossati, S., Ruzzante, S., Cavarretta, R., Filippi, M., Caputo, D., & Ferrante, P. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00431-3 · Cited by 62
Non‐Th2 Regulatory T‐Cell Control of Th1 Autoimmunity
Bach, J. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00945.x · Cited by 52
Sánchez, A., Rojo, J. M., & Rojo, J. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324259 · Cited by 48
Immunotherapeutic approaches in multiple sclerosis
Adorini, L. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.04.014 · Cited by 41
Applying a new generation of genetic maps to understand human inflammatory disease
Hafler, D. A., & Jager, P. L. D. (2005) · Nature reviews. Immunology · doi:10.1038/nri1532 · Cited by 31
Self-citationBrod, S. A., Nelson, L. D., Khan, M., & Wolinsky, J. S. (1997) · International Journal of Neuroscience · doi:10.3109/00207459709000633 · Cited by 13
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N., & Mills, K. H. G. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 945
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933
Keeping It All Going—Complement Meets Metabolism
Kolev, M., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 812
Metadata
- Authors
- Astier, A. L., Meiffren, G., Freeman, S., & Hafler, D. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-12-01
- Volume
- 116
- Issue
- 12
- Pages
- 3252-3257
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2050638098
- Cited by
- 292
- References
- 40
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.